Webinars For healthcare professionals

Live Webinars

Upcoming webinars

On-Demand Webinars

Watch videos

Medtronic Extended infusion set:  Summarizing the science

  • Description:  This webinar will dive into the science behind Medtronic’s new Extended infusion set.
  • Who should attend:  Healthcare professionals who manage patients on insulin pump systems
  • Speaker:  Sarnath Chattaraj, PhD, Sr. Research Director, Consumables R&D
  • Date:
    • Wednesday, December 7th at 3 PM PT | 6 PM ET
    • Thursday, December 15th at 5 PM PT | 8 PM ET

The Medtronic Extended infusion set.

Optimizing MiniMed™ 770G system therapy

  • Description:  Learn how to collaborate with patients to optimize the MiniMed™ 770G system. This program will review report interpretation, focus on addressing behaviors that impact therapy, offer practical examples and provide strategies for success.
  • Who should attend:  Healthcare professionals currently managing patients on the MiniMed™ 770G system
  • Speaker:  Dana E. Stallings, DNP, APRN, FNP-C, CDCES, BC-ADM
  • Date: Wednesday, January 18th at 4 PM PT | 7 PM ET

The MiniMed 770G insulin pump system.

Medtronic Diabetes Digest

Quartly articles on the latest research in diabetes technology, practical training tips for your patients, and updates on Medtronic products.

Read articles

Leading Innovation

For more than 30 years, Medtronic has been committed to transforming diabetes care. Learn what's coming next.

See what's in the pipeline

User guides and manuals

Browse our library to find reference materials for our Medtronic Diabetes products.


Visit library

Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library